Avedro Competitors and Similar CompaniesClear all

Avedro's competitors and similar companies include OptiNose.
Avedro
Avedro
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Founding Date
Founding Date
2002
Founding Date
2000
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Waltham, US HQ
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Employees
Employees
122
Employees
2048% decrease

Financial

Revenue (est.)
Revenue (est.)
$27.7m (FY, 2018)
Revenue (est.)
$78.2m (FY, 2024)
Cost of goods
Cost of goods
$10.9m (FY, 2018)
Cost of goods
$7.2m (FY, 2024)
Gross profit
Gross profit
$16.8m (FY, 2018)
Gross profit
$71m (FY, 2024)
Net income
Net income
($25.1m) (FY, 2018)
Net income
($21.5m) (FY, 2024)

Operating

Patents (US)
Patents (US)
15 (Mar, 2019)
Patents (US)
43 (Jun, 2017)
Trademarks (US)
Trademarks (US)
10 (Mar, 2019)
Trademarks (US)
3 (Jun, 2017)

Funding

Total funding raised
Total funding raised
$ 67.6m
Total funding raised
$ 120.5m
For sources of this data, please see the company profile

View Company Profiles

OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.

View company